3Tolusso B, Fabris M, Gremese E, et al. Platelet GPⅡb/Ⅲa(PIA 1/2)polymorphism in SLE: clinical and laboratory association [J ]. Ann Rheum Dis, 2003, 62(8): 781-2.
4Koltai M, Hosford D, Guinot P, et al. Platelet activating factor (PAF).A review of its efects, antagonists possible future clinical applications (Part Ⅰ)[J]. Drugs, 1991, 42(1): 9-29.
5Ruiz-Ortega M, Bustos C, Plaza J J, et al. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by plateletactivating-factor stimulation[J]. Nephrol Dial Transplant, 1998, 13(4): 886-92.
